Gain Therapeutics (GANX) Preferred Shares (2020)
Gain Therapeutics (GANX) has 1 years of Preferred Shares data on record, last reported at $297.0 in Q4 2020.
- For Q4 2020, Preferred Shares changed N/A year-over-year to $297.0; the TTM value through Dec 2020 reached $297.0, changed N/A, while the annual FY2020 figure was $297.0, N/A changed from the prior year.
- Preferred Shares reached $297.0 in Q4 2020 per GANX's latest filing.
- Across five years, Preferred Shares topped out at $297.0 in Q4 2020 and bottomed at $297.0 in Q4 2020.